6 Jan
2014

New case law suggests a bumpy ride for Bolar exemption in Poland

Patent law sets out specific provisions with respect to the protection of medicinal products and biotechnological inventions. These provisions are determined by two main factors: medicinal products are difficult to discover and develop, and at the same time – being chemical compounds or mixtures thereof – they are extremely susceptible to copying. That is why manufacturers of original medicines (originators) protect their products using patents. The exclusive rights granted by patents enable them to recover costs incurred in developing a new product and fund further research.